• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Consumer Defensive·605198.SS
Share

Yantai North Andre Juice Co., Ltd. Stocks

CN¥ 56.78Last Updated 15.07.2026

Issuer Rating

4/7
Performance

Average

Risk

Limited

Recommendation

Hold

Market Cap

CN¥ 2.36B

CN¥ 56.78
Key Takeaways

Risk factor

Good trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Strong margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Yantai North Andre Juice Co., Ltd. specializes in the production and distribution of a diverse range of fruit and vegetable products within China. Its extensive product portfolio encompasses various fruit and vegetable beverages, including concentrates such as apple, pear, haw, sweet potato, and strawberry. The company also produces peach and strawberry purees and juices, along with cloudy apple juice. Additionally, they offer apple and pear fructose, as well as bottled drinking water. Beyond food products, the company is involved in manufacturing iron drums for juice packaging. Its operations extend to sourcing agricultural and sideline products, and it engages in the import and export of both goods and technology. A significant part of their offering includes lemon and orange juices, along with their respective oils and essences. The company also undertakes the comprehensive biological utilization of by-products like apple essence, pomace, and various vegetables. It facilitates the import and export of juice and pulp, and provides essential goods storage services. Globally, Yantai North Andre Juice has a strong international presence, distributing its products across the rest of Asia, Europe, North America, Africa, Oceania, and South America. Established in 1996, the company maintains its headquarters in Yantai, located in the People's Republic of China.

Company Valuation

Greatly overvalued
1/7

Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EB

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
4/7

The average target price of 605198.SS is 166 and suggests 191% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to i

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

15.07.2026 07:30

Chinese AI developer DeepSeek has begun preparations for an IPO next year — Bloomberg

15.07.2026 03:24

Lucid's stock plummeted following news of a possible bankruptcy. At one point, it was down 57%.

15.07.2026 02:16

"The Prisoner's Dilemma": JPMorgan Warns of a Threat to Coinbase and Circle's Profits

15.07.2026 01:24

Inflation data pushed the indices higher. Software developers are under pressure again

15.07.2026 00:57

Biogen shares fell after disappointing data on its Alzheimer's drug

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026